Uploaded on May 31, 2024
According to the latest research report by IMARC Group, The global vertebroplasty and kyphoplasty needles market size reached US$ 884.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,334.2 Million by 2032, exhibiting a growth rate (CAGR) of 4.68% during 2024-2032. More Info:- https://www.imarcgroup.com/vertebroplasty-kyphoplasty-needles-market
Vertebroplasty and Kyphoplasty Needles Market by Product Type, Distribution Channel, End User 2024-2032
Global Vertebroplasty
and Kyphoplasty Needles
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
A cc o r d i ng t o t h e l a te s t r e p o r t b y I MA R C Gr o u p , t i t l e d " V er t e b ro p l a s t y a n d
K yp h o p la s t y N e e d l es M a r ke t : G l o b a l I n d u s t r y T r e n d s , S h a re , S i z e , G ro w t h ,
Op p o r tu n i t y a n d F o re c a s t 2 0 24 - 2 0 32 , " t h e g l ob a l v e r te b r o p l a s t y a n d k y p ho p l a s ty
ne e d l e s ma r k e t s i z e r e a c he d U S $ 8 8 4 . 0 M i l l i o n i n 2 0 2 3 .
Report Fac tors Af fec t ing the Growth o f the Ver tebrop last y and Kyphop last y Need les Indust ry :
Increas ing Preva lence o f Os teoporos is and Ver t ebra l Compress ion Frac tures:
Highlight and T he r i s i n g o c c u r r e n c e o f o s t e o p o ro s i s a n d v e r t eb r a l co m p r es s i o n f r a c tu r e s a m on g t h e
ma s s e s i s p r op e l l i n g t h e m a r ke t g r o w t h . T h e s e c on d i t i o n s , p r i ma r i l y a f f e c t i n g t h e
e l d e r l y p op u l a t i o n , a r e d r i v i n g t h e d e ma n d f o r m i n i m a l l y i n v as i v e (M I ) s u r g i ca l
Description p r o c e d u r e s , su c h as v e r te b r o p l as t y a nd k y ph o p l a s t y .
T he s e p r oc e d u r es a r e f a v o r e d f o r t h e i r b e n e f i t s i n p a i n r e l i e f a n d sp i n a l s ta b i l i z a t i o n ,
ma k i n g t h e m c r u c i a l i n t h e m a n ag e m e n t o f o s t e op o r o t i c f r a c t u r e s . T h i s i s s u pp o r te d b y
he a l t h c a re i n i t i a t i v es f o c u se d o n bo n e h e a l t h a n d th e p r ev en t i o n o f f r a c t u r e s ,
em p h a s i z i n g t h e i m p o r ta n c e o f e a r l y i n te r v e n t i o n an d t h e a d op t i o n o f e f f e c t i v e
t r e a t me n t mo d a l i t i e s l i k e v e r t e b r op l a s t y a n d ky p h o p l as t y .
Technologica l Advancements in Surg ica l Equipment :
I nnovat ions i n need le des ign and func t iona l i t y , such as improved p rec i s ion ,
b iocompa t ib i l i t y , and t he in t roduc t ion o f mat e r ia l s t ha t enhance durab i l i t y and
pe r f o rmance, a re con t r i bu t i ng t o the e f f ec t i veness and sa f e ty o f ve r t eb rop las ty
Report and kyphop las ty p rocedures . These advancemen ts f ac i l i t a te eas ie r nav iga t ion th rough the ve r t eb ra l body , r educ ing procedure t ime and enhanc ing pa t ien t
ou tcomes .
Highlight and Add i t i ona l l y , t he in tegra t ion o f imag ing t echn iques w i t h su rg ica l i ns t r umen ts i s
improv ing t he accuracy o f need le p lacemen t , m in im iz ing comp l i ca t ions and
Description promot ing fas t e r recovery . Manu fac t u rer s a re con t inuous l y inves t ing i n research and deve lopmen t (R&D) , wh ich i s resu l t i ng in t he in t roduc t i on o f more
soph is t i ca ted so lu t ions , f u r t he r d r i v i ng adop t i on among hea l thcare p rov ide rs .
Growing Awareness and Acceptance of Minimal ly Invasive (MI )
Procedures:
The inc reas ing awareness and accep tance o f m in ima l l y invas ive (M I ) p rocedures
among bo t h hea l thcare p ro fess iona l s and pa t i en ts i s o f fe r ing a f avo rab le marke t
ou t l ook . M I sp ine su rger ies , i nc lud ing ve r t eb rop las t y and kyphop las ty , o f f e r
numerous advan tages over t rad i t i ona l open surger ies , such as reduced pa in ,
l ower r i sk o f i n fec t ion , sho r t e r hosp i ta l s t ays , and qu icke r recovery t imes .
Th is sh i f t towards less invas ive t rea tmen t op t ions i s suppor ted by a g rowing
body o f c l in ica l ev idence demons t ra t ing the i r e f f i cacy and sa fe ty i n manag ing
ve r teb ra l compress ion f rac tu res . Hea l thca re sys tems wor ldwide a re adop t ing
these techn iques , d r i ven by pa t ien t p re fe rence fo r less invas ive in te rven t ions
and the po ten t ia l f o r cos t sav ings .
Report
Request for a PDF sample o f th is repor t :
h t tps : / /www. imarcgroup .com/ver teb rop las ty -kyphop las ty -need les -marke t / reque
Highlight and s tsamp le
Description
Report Description
Global Vertebroplasty and Kyphoplasty Needles Market Trends:
The g rowing in t eg ra t ion o f smar t t echno log ies and d ig i t a l hea l th so lu t ions t o enhance p rocedura l ou tcomes and
pa t ien t exper iences i s pos i t i ve ly in f l uenc ing the marke t . Th is inc ludes the deve lopm en t o f need les equ ipped w i th
sensors and connec t i v i t y f ea t u res tha t can p rov ide rea l - t ime feedback on the p lacement and cemen t d is t r ibu t ion
du r ing p rocedures .
Add i t i ona l l y , t he use o f a r t i f i c ia l i n te l l i gence (A I ) and mach ine lea rn ing (ML) a lgo r i t hms fo r p red ic t i ve ana l y t i cs in
pa t ien t se lec t ion and p rocedura l p lann ing i s ga in ing t rac t ion . These t echno log ies can he lp i n i den t i f y ing pa t ien ts who
are mos t l i ke ly t o bene f i t f r om ve r t eb rop las ty o r kyphop las ty , t hereby op t im iz ing t rea t ment ou t comes and reduc ing the
r i sk o f compl i ca t i ons .
Look ing fo rward , the market to reach US$ 1 , 334 .2 Mi l l i on by 2032, exh ib i t ing a g rowth ra te (CAGR) o f 4 .68%
dur ing 2024-2032 .
V i ew Report TOC, F igures and Tab les : h t tps: / / www. i marcgroup .com/ver tebrop las ty -kyphop lasty-need les-market
Breakup by Procedure:
• Kyphoplasty Procedures
• Vertebroplasty Procedures
Breakup by End Use:
• Hospitals
Report • Ambulatory Surgical Centers
Segmentation
Breakup by Region:
• North America
• Europe
• Asia-Pacifi c
• Lat in America
• Middle East and Afr ica
• Adroit Manufactur ing Company
• Biopsybel l S.R.L. Società Unipersonale
• IZI Medical Products (Halma plc)
• Jayon Implants Pvt.Ltd.
Competitive • Medtronic Plc
Landscape • Merit Medical Systems, Inc.
• MOLLER Medical GmbH
with Key
• Stryker Corporat ion
Players • Suretech Medical INC
• Swastik Enterprise
• Tecres S.p.A.
• Teknimed
How has the global vertebroplasty and kyphoplasty
needles market performed so far, and how will it
perform in the coming years?
What are the drivers, restraints, and opportunities in
the global vertebroplasty and kyphoplasty needles
market?
What is the impact of each driver, restraint, and
Key opportunity on the global vertebroplasty and kyphoplasty needles market?
Questions
What are the key regional markets?
Answered in
the Report Which countries represent the most attractive vertebroplasty and kyphoplasty needles market?
What is the breakup of the market based on procedure?
Which is the most attractive procedure in the
vertebroplasty and kyphoplasty needles market?
What is the breakup of the market based on the end
use?
Which is the most attractive end use in the
vertebroplasty and kyphoplasty needles market?
Key What is the competitive structure of the global
vertebroplasty and kyphoplasty needles market?
Questions
Answered in Who are the key players/companies in the global vertebroplasty and kyphoplasty needles market?
the Report
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h2 . 4 . 2 T o p - D o w n A p p r o a c h
2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 G l o b a l V e r t e b r o p l a s t y a n d K y p h o p l a s t y N e e d l e s M a r k e t - I n t r o d u c t i o n
Contents 4 . 1 O v e r v i e w4 . 2 M a r k e t D y n a m i c s
4 . 3 I n d u s t r y T r e n d s
4 . 4 C o m p e t i t i v e I n t e l l i g e n c e
5 G l o b a l V e r t e b r o p l a s t y a n d K y p h o p l a s t y N e e d l e s M a r k e t L a n d s c a p e
5 . 1 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
5 . 2 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 G l o b a l V e r t e b r o p l a s t y a n d K y p h o p l a s t y N e e d l e s M a r k e t - B r e a k u p b y P r o c e d u r e
6 . 1 K y p h o p l a s t y P r o c e d u r e s
6 . 1 . 1 O v e r v i e w
6 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3 M a r k e t S e g m e n t a t i o n
6 . 1 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 2 V e r t e b r o p l a s t y P r o c e d u r e s
6 . 2 . 1 O v e r v i e w
6 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 2 . 3 M a r k e t S e g m e n t a t i o n
6 . 2 . 3 . 1 D i r e c t i o n a l V e r t e b r o p l a s t y N e e d l e s
6 . 2 . 3 . 2 S t r a i g h t V e r t e b r o p l a s t y N e e d l e s
6 . 2 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 3 A t t r a c t i v e I n v e s t m e n t P r o p o s i t i o n b y P r o c e d u r e
7 G l o b a l V e r t e b r o p l a s t y a n d K y p h o p l a s t y N e e d l e s M a r k e t -
B r e a k u p b y E n d U s e
7 . 1 H o s p i t a l s
7 . 1 . 1 O v e r v i e w
7 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
Table of 7 . 1 . 3 M a r k e t S e g m e n t a t i o n7 . 1 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
7 . 2 A m b u l a t o r y S u r g i c a l C e n t e r s
7 . 2 . 1 O v e r v i e w
Contents 7 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
7 . 2 . 3 M a r k e t S e g m e n t a t i o n
7 . 2 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
7 . 3 A t t r a c t i v e I n v e s t m e n t P r o p o s i t i o n b y E n d U s e
8 G l o b a l V e r t e b r o p l a s t y a n d K y p h o p l a s t y N e e d l e s M a r k e t –
B r e a k u p b y R e g i o n
8 . 1 N o r t h A m e r i c a
8 . 1 . 1 U n i t e d S t a t e s
8 . 1 . 1 . 1 M a r k e t D r i v e r s
8 . 1 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
8 . 1 . 1 . 3 M a r k e t B r e a k u p b y P r o c e d u r e
8 . 1 . 1 . 4 M a r k e t B r e a k u p b y E n d U s e
8 . 1 . 1 . 5 K e y P l a y e r s
8 . 1 . 1 . 6 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
F o r m o r e i n f o r m a t i o n , v i s i t :
ht t ps : / /w ww. i ma rc gro up . c o m /v e r teb ro p l a s t y - kyph o p l a s t y -nee
d les -ma rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us:
Comments